Sky Medical Technology

About

Sky Medical develops bioelectronic medicine to prevent and treat acute and chronic circulatory conditions.

High Wycombe,Buckinghamshire,United Kingdom
11 - 50

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $13.50M
Industries: Biotechnology,Health Care,Medical,Neuroscience
Founded date: Jan 1, 2006
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Sky Medical Technology Ltd.
Also Known As: Geko,Firstkind Ltd.,Firefly Recovery,OnPulse,Firefly

Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatory conditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$59.55M

Sky Medical Technology has raised a total of $59.55M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2017 from a Secondary Market round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 1, 2017	Secondary Market	$16M	1	Barvest Ventures	—	Detail
Sep 1, 2017	Series B	$13.50M	5	Juno Capital Partners	—	Detail
Jun 18, 2015	Grant	$1.40M	1	Innovate UK	—	Detail
Feb 1, 2015	Series A	$15M	4	Deepbridge Capital Juno Capital Partners	—	Detail
Feb 1, 2014	Series Unknown	$13M	4	Juno Capital Partners Longbow Capital	—	Detail

Investors

Number of Lead Investors

Number of Investors

9

13

Sky Medical Technology is funded by 13 investors. Barvest Ventures and Juno Capital Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Barvest Ventures	Yes	Secondary Market
Juno Capital Partners	Yes	Series B
Innovate UK	Yes	Grant
Longbow Capital	Yes	Series Unknown
Revera Home Health Business	—	Series B
Baranco	—	Series B
Deepbridge Capital	—	Series B
Nissha Co., Ltd.	—	Series B
Caliburn Capital	—	Series A
Nigel Rudd	—	Series A